NNNN

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Dollar change +0.27
Percentage change 3.91	%

Index	-	P/E	70.29	EPS (ttm)	0.10	Insider Own	4.78%	Shs Outstand	43.89M	Perf Week	7.34%
Market Cap	314.70M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	41.79M	Perf Month	-
Income	4.30M	PEG	-	EPS next Q	-	Inst Own	4.78%	Short Float	0.17%	Perf Quarter	-
Sales	9.50M	P/S	33.13	EPS this Y	-	Inst Trans	-	Short Ratio	0.25	Perf Half Y	-
Book/sh	0.44	P/B	16.30	EPS next Y	-	ROA	25.20%	Short Interest	0.07M	Perf Year	-
Cash/sh	0.23	P/C	30.55	EPS next 5Y	-	ROE	26.60%	52W Range	5.18 - 7.70	Perf YTD	24.26%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-6.88%	Beta	-
Dividend TTM	-	Quick Ratio	28.30	Sales past 5Y	-	Gross Margin	57.60%	52W Low	38.42%	ATR (14)	0.63
Dividend Ex-Date	-	Current Ratio	35.60	EPS Y/Y TTM	-	Oper. Margin	43.50%	RSI (14)	-	Volatility	11.32% -
Employees	-	Debt/Eq	0.00	Sales Y/Y TTM	-	Profit Margin	45.60%	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	760.00%	Payout	0.00%	Rel Volume	0.85	Prev Close	6.90
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	93.30%	Earnings	-	Avg Volume	286.48K	Price	7.17
SMA20	8.25%	SMA50	8.92%	SMA200	8.92%	Trades		Volume	242,112	Change	3.91%

Feb-20-25 09:50AM	Anbio Biotechnology Announces Closing of Initial Public Offering (GlobeNewswire)
Feb-18-25 06:10PM	Anbio Biotechnology Announces Pricing of Initial Public Offering (GlobeNewswire)

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves over-the-counter, point-of-care testing, and laboratory markets. The company was incorporated in 2021 and is based in Frankfurt am Main, Germany.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Anbio Biotechnology

Upgrade your FINVIZ experience